Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2015

View Archived Issues

MI-mAbs immunotechnology center launched in France

EMD Serono amends agreement with Opexa to support Tcelna development

Radius Health acquires license to develop and market RAD-1901 in Japan

Spry-2 shows potential as a prognostic biomarker in ovarian cancer

MazF-modified T cells are safe and persistant in aviremic HIV patients

Novel HPV vaccine increases seroconversion levels after each vaccination

TWi Biotechnology receives rare disease drug designation for AC-203 in Taiwan

MedImmune and Joslin Diabetes Center form new collaboration for metabolic disease research

LDC receives grants to develop new drug candidates

Illumina and Merck Serono collaborate to develop universal NGS-based oncology diagnostic

Novel crossmab antibody shows efficacy in neovascular disease of the eye

Madison Vaccines confirms program expansions for prostate cancer vaccines

Stratatech reports topline results from proof-of-concept study of StrataGraft skin tissue

Merrimack uses RNAscope to select patients for phase II NSCLC trial of MM-121

Halozyme Therapeutics selects first product candidate under Janssen collaboration

Boehringer Ingelheim divulges BRD4/HUNK1 inhibitors

FDA accepts for review Spectrum's Captisol-Enabled Melphalan NDA

Multi-kinase inhibitor shows potential for AMD

Ocular Therapeutix reports phase III results for dexamethasone punctal plug

FDA approves Unituxin for pediatric patients with high-risk neuroblastoma

Merck & Co.'s pembrolizumab is first drug accepted in U.K. Early Access to Medicines Scheme

Ophthotech achieves new milestone under Fovista agreement with Novartis

Interim analysis completed for phase III trial of AM-101 in post-acute tinnitus

Merck & Co. patents PAR-1 antagonists

Allergan describes S1P1 receptor modulators

Roche and Genetech disclose MAP3K14 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...